Dominik Wiedemann, Martin H Bernardi, Klaus Distelmaier, Georg Goliasch, Christian Hengstenberg, Alexander Hermann, Michael Holzer, Konrad Hoetzenecker, Walter Klepetko, György Lang, Andrea Lassnigg, Günther Laufer, Ingrid A M Magnet, Klaus Markstaller, Martin Röggla, Bernhard Rössler, Peter Schellongowski, Paul Simon, Edda Tschernko, Roman Ullrich, Daniel Zimpfer, Thomas Staudinger
{"title":"[对 COVID-19 患者进行体外膜氧合（ECMO）的建议]。","authors":"Dominik Wiedemann, Martin H Bernardi, Klaus Distelmaier, Georg Goliasch, Christian Hengstenberg, Alexander Hermann, Michael Holzer, Konrad Hoetzenecker, Walter Klepetko, György Lang, Andrea Lassnigg, Günther Laufer, Ingrid A M Magnet, Klaus Markstaller, Martin Röggla, Bernhard Rössler, Peter Schellongowski, Paul Simon, Edda Tschernko, Roman Ullrich, Daniel Zimpfer, Thomas Staudinger","doi":"10.1007/s00740-020-00349-x","DOIUrl":null,"url":null,"abstract":"<p><p>The pandemic from the SARS-CoV‑2 Virus is currently challenging health care systems all over the world. Maintaining appropriate staffing and resources in healthcare facilities is essential to guarantee a safe work environment for healthcare personnel and safe patient care. Extracorporeal membrane oxygenation (ECMO) represents a valuable therapeutic option in patients with severe heart or lung failure. Although only a limited proportion of COVID-19 patients develops respiratory or circulatory failure that is refractory to conventional therapies, it is of utmost importance to clearly define criteria for the use of ECMOs in this steadily growing patient population. The ECMO working group of the Medical University of Vienna has established the following recommendations for ECMO support in COVID-19 patients.</p>","PeriodicalId":75323,"journal":{"name":"Wiener klinisches Magazin : Beilage zur Wiener klinischen Wochenschrift","volume":"23 4","pages":"168-173"},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286215/pdf/","citationCount":"0","resultStr":"{\"title\":\"[Recommendations for Extracorporeal Membrane Oxygenation (ECMO) in COVID-19 Patients].\",\"authors\":\"Dominik Wiedemann, Martin H Bernardi, Klaus Distelmaier, Georg Goliasch, Christian Hengstenberg, Alexander Hermann, Michael Holzer, Konrad Hoetzenecker, Walter Klepetko, György Lang, Andrea Lassnigg, Günther Laufer, Ingrid A M Magnet, Klaus Markstaller, Martin Röggla, Bernhard Rössler, Peter Schellongowski, Paul Simon, Edda Tschernko, Roman Ullrich, Daniel Zimpfer, Thomas Staudinger\",\"doi\":\"10.1007/s00740-020-00349-x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The pandemic from the SARS-CoV‑2 Virus is currently challenging health care systems all over the world. Maintaining appropriate staffing and resources in healthcare facilities is essential to guarantee a safe work environment for healthcare personnel and safe patient care. Extracorporeal membrane oxygenation (ECMO) represents a valuable therapeutic option in patients with severe heart or lung failure. Although only a limited proportion of COVID-19 patients develops respiratory or circulatory failure that is refractory to conventional therapies, it is of utmost importance to clearly define criteria for the use of ECMOs in this steadily growing patient population. The ECMO working group of the Medical University of Vienna has established the following recommendations for ECMO support in COVID-19 patients.</p>\",\"PeriodicalId\":75323,\"journal\":{\"name\":\"Wiener klinisches Magazin : Beilage zur Wiener klinischen Wochenschrift\",\"volume\":\"23 4\",\"pages\":\"168-173\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286215/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Wiener klinisches Magazin : Beilage zur Wiener klinischen Wochenschrift\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/s00740-020-00349-x\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2020/6/10 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Wiener klinisches Magazin : Beilage zur Wiener klinischen Wochenschrift","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s00740-020-00349-x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/6/10 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
[Recommendations for Extracorporeal Membrane Oxygenation (ECMO) in COVID-19 Patients].
The pandemic from the SARS-CoV‑2 Virus is currently challenging health care systems all over the world. Maintaining appropriate staffing and resources in healthcare facilities is essential to guarantee a safe work environment for healthcare personnel and safe patient care. Extracorporeal membrane oxygenation (ECMO) represents a valuable therapeutic option in patients with severe heart or lung failure. Although only a limited proportion of COVID-19 patients develops respiratory or circulatory failure that is refractory to conventional therapies, it is of utmost importance to clearly define criteria for the use of ECMOs in this steadily growing patient population. The ECMO working group of the Medical University of Vienna has established the following recommendations for ECMO support in COVID-19 patients.
![[Recommendations for Extracorporeal Membrane Oxygenation (ECMO) in COVID-19 Patients].](https://img.booksci.cn/booksciimg/2020-1/2023121778284112627852329873975.jpg)
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
